Chemoinformaics analysis of dioxindole-3-acetic acid
| Molecular Weight | 293.395 | nRot | 4 |
| Heavy Atom Molecular Weight | 274.243 | nRig | 12 |
| Exact Molecular Weight | 293.108 | nRing | 2 |
| Solubility: LogS | -4.874 | nHRing | 1 |
| Solubility: LogP | 2.816 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 1 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 45.8871 |
| nHD | 1 | BPOL | 40.2789 |
| QED | 0.683 |
| Synth | 3.332 |
| Natural Product Likeliness | 0.303 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.005 |
| HIA | 0.021 |
| CACO-2 | -5.003 |
| MDCK | 0.0000203 |
| BBB | 0.943 |
| PPB | 0.979203 |
| VDSS | 0.905 |
| FU | 0.0308786 |
| CYP1A2-inh | 0.19 |
| CYP1A2-sub | 0.935 |
| CYP2c19-inh | 0.149 |
| CYP2c19-sub | 0.918 |
| CYP2c9-inh | 0.077 |
| CYP2c9-sub | 0.151 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.523 |
| CYP3a4-inh | 0.069 |
| CYP3a4-sub | 0.92 |
| CL | 2.757 |
| T12 | 0.716 |
| hERG | 0.016 |
| Ames | 0.196 |
| ROA | 0.084 |
| SkinSen | 0.156 |
| Carcinogencity | 0.765 |
| EI | 0.016 |
| Respiratory | 0.547 |
| NR-Aromatase | 0.027 |
| Antiviral | Yes |
| Prediction | 0.788876 |